Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat

Psychoneuroendocrinology

Volumn 38, Issue 4, 2013, Pages 560-571

  Steiner, Michel A ^a   Sciarretta, Carla ^a   Brisbare Roch, Catherine ^a   Strasser, Daniel S ^a   Studer, Rolf ^a   Jenck, Francois ^a  

^a ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

ACTH; Adrenal; Almorexant; Corticosterone; HPA axis; Orexin; Pituitary; Rats; Stress

Indexed keywords

ALMOREXANT; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL STRESS; CIRCADIAN RHYTHM; CORTICOSTERONE RELEASE; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENDOCRINE FUNCTION; HORMONE RELEASE; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP WAKING CYCLE; TELEMETRY; WAKEFULNESS;

ACETAMIDES; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CIRCADIAN RHYTHM; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPNOTICS AND SEDATIVES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOQUINOLINES; MALE; NEUROPEPTIDES; OREXIN RECEPTORS; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; RATS; RESTRAINT, PHYSICAL; SLEEP STAGES; WAKEFULNESS;

EID: 84875051780     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.07.016     Document Type: Article

References (61)

1. Al-Barazanji K.A., Wilson S., Baker J., Jessop D.S., Harbuz M.S. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol. 2001, 13:421-424.
2. Arihara Z., Takahashi K., Murakami O., Totsune K., Sone M., Satoh F., et al. Immunoreactive orexin-A in human plasma. Peptides 2001, 22:139-142.
3. Armario A. The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors?. CNS Neurol. Disord. Drug Targets 2006, 5:485-501.
4. Berridge C.W., Espana R.A., Vittoz N.M. Hypocretin/orexin in arousal and stress. Brain Res. 2010, 1314:91-102.
5. Besset A., Bonardet A., Billiard M., Descomps B., de Paulet A.C., Passouant P. Circadian patterns of growth hormone and cortisol secretions in narcoleptic patients. Chronobiologia 1979, 6:19-31.
6. Brisbare-Roch C., Dingemanse J., Koberstein R., Hoever P., Aissaoui H., Flores S., et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat. Med. 2007, 13:150-155.
7. Carter M.E., Borg J.S., de Lecea L. The brain hypocretins and their receptors: mediators of allostatic arousal. Curr. Opin. Pharmacol. 2009, 9:39-45.
8. Chang H., Saito T., Ohiwa N., Tateoka M., Deocaris C.C., Fujikawa T., et al. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats. Neurosci. Res. 2007, 57:462-466.
9. Chen C.T., Dun S.L., Kwok E.H., Dun N.J., Chang J.K. Orexin A-like immunoreactivity in the rat brain. Neurosci. Lett. 1999, 260:161-164.
10. Copinschi G., Akseki E., Moreno-Reyes R., Leproult R., L'Hermite-Baleriaux M., Caufriez A., et al. Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep 1995, 18:417-424.
11. Date Y., Mondal M.S., Matsukura S., Ueta Y., Yamashita H., Kaiya H., et al. Distribution of orexin/hypocretin in the rat median eminence and pituitary. Brain Res. Mol. Brain Res. 2000, 76:1-6.
12. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:748-753.
13. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:322-327.
14. Desarnaud F., Murillo-Rodriguez E., Lin L., Xu M., Gerashchenko D., Shiromani S.N., et al. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004, 27:851-856.
15. Furlong T.M., Vianna D.M., Liu L., Carrive P. Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur. J. Neurosci. 2009, 30:1603-1614.
16. Girotti M., Weinberg M.S., Spencer R.L. Differential responses of hypothalamus-pituitary-adrenal axis immediate early genes to corticosterone and circadian drive. Endocrinology 2007, 148:2542-2552.
17. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:10911-10916.
18. Heinonen M.V., Purhonen A.K., Makela K.A., Herzig K.H. Functions of orexins in peripheral tissues. Acta Physiol. (Oxf.) 2008, 192:471-485.
19. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 2000, 270:318-323.
20. Jaszberenyi M., Bujdoso E., Pataki I., Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J. Neuroendocrinol. 2000, 12:1174-1178.
21. Johren O., Gremmels J.A., Qadri F., Dendorfer A., Dominiak P. Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes. Peptides 2006, 27:2764-2769.
22. Johren O., Neidert S.J., Kummer M., Dendorfer A., Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001, 142:3324-3331.
23. Jones D.N., Gartlon J., Parker F., Taylor S.G., Routledge C., Hemmati P., et al. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) 2001, 153:210-218.
24. Kagerer S.M., Eichholz C., Johren O. Orexins/hypocretins increase the promoter activity of selective steroidogenic enzymes. Peptides 2011, 32:839-843.
25. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R581-R593.
26. Kirchgessner A.L., Liu M. Orexin synthesis and response in the gut. Neuron 1999, 24:941-951.
27. Kohsaka A., Watanobe H., Kakizaki Y., Suda T., Schioth H.B. A significant participation of orexin-A, a potent orexigenic peptide, in the preovulatory luteinizing hormone and prolactin surges in the rat. Brain Res. 2001, 898:166-170.
28. Kok S.W., Roelfsema F., Overeem S., Lammers G.J., Strijers R.L., Frolich M., et al. Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker. J. Clin. Endocrinol. Metab. 2002, 87:5085-5091.
29. Kovacs K.J. c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem. Int. 1998, 33:287-297.
30. Kuru M., Ueta Y., Serino R., Nakazato M., Yamamoto Y., Shibuya I., et al. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 2000, 11:1977-1980.
31. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton. Neurosci. 2011, 161:20-27.
32. Lopez M., Senaris R., Gallego R., Garcia-Caballero T., Lago F., Seoane L., et al. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 1999, 140:5991-5994.
33. Lu X.Y., Bagnol D., Burke S., Akil H., Watson S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav. 2000, 37:335-344.
34. Malendowicz L.K., Hochol A., Ziolkowska A., Nowak M., Gottardo L., Nussdorfer G.G. Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland. Int. J. Mol. Med. 2001, 7:401-404.
35. Malendowicz L.K., Tortorella C., Nussdorfer G.G. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J. Steroid Biochem. Mol. Biol. 1999, 70:185-188.
36. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001, 435:6-25.
37. Matsumura K., Tsuchihashi T., Abe I. Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 2001, 37:1382-1387.
38. Nishino S., Mignot E. Article reviewed: plasma orexin-A is lower in patients with narcolepsy. Sleep Med. 2002, 3:377-378.
39. Ouedraogo R., Naslund E., Kirchgessner A.L. Glucose regulates the release of orexin-A from the endocrine pancreas. Diabetes 2003, 52:111-117.
40. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr. Rev. 2001, 22:502-548.
41. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
42. Randeva H.S., Karteris E., Grammatopoulos D., Hillhouse E.W. Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J. Clin. Endocrinol. Metab. 2001, 86:4808-4813.
43. Russell S.H., Small C.J., Dakin C.L., Abbott C.R., Morgan D.G., Ghatei M.A., et al. The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J. Neuroendocrinol. 2001, 13:561-566.
44. Sakamoto F., Yamada S., Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 2004, 118:183-191.
45. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
46. Sakurai T., Nagata R., Yamanaka A., Kawamura H., Tsujino N., Muraki Y., et al. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 2005, 46:297-308.
47. Samson W.K., Taylor M.M. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R1140-R1145.
48. Saper C.B., Cano G., Scammell T.E. Homeostatic, circadian, and emotional regulation of sleep. J. Comp. Neurol. 2005, 493:92-98.
49. Seoane L.M., Tovar S.A., Perez D., Mallo F., Lopez M., Senaris R., et al. Orexin A suppresses in vivo GH secretion. Eur. J. Endocrinol. 2004, 150:731-736.
50. Silveyra P., Catalano P.N., Lux-Lantos V., Libertun C. Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E820-E828.
51. Steiner, M.A., Lecourt, H., Jenck, F., 2012a. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology (Berl.) May 17. [Epub ahead of print]. doi:10.1007/s00213-012-2736-7.
52. Steiner, M.A., Lecourt, H., Jenck, F., 2012b. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat. Int. J. Neuropsychopharmacol. March 21, 1-16 [Epub ahead of print]. doi:10.1017/S1461145712000193.
53. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998, 438:71-75.
54. Winrow C.J., Gotter A.L., Cox C.D., Doran S.M., Tannenbaum P.L., Breslin M.J., et al. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist. J. Neurogenet. 2011, 25:52-61.
55. Winrow C.J., Gotter A.L., Cox C.D., Tannenbaum P.L., Garson S.L., Doran S.M., et al. Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomnia. Neuropharmacology 2011, 62:978-987.
56. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 2004, 24:11439-11448.
57. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol. 2006, 494:845-861.
58. Yoshida Y., Fujiki N., Nakajima T., Ripley B., Matsumura H., Yoneda H., et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur. J. Neurosci. 2001, 14:1075-1081.
59. Zeitzer J.M., Buckmaster C.L., Landolt H.P., Lyons D.M., Mignot E. Modafinil and gamma-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep. Behav. Pharmacol. 2009, 20:643-652.
60. Zhang W., Shimoyama M., Fukuda Y., Kuwaki T. Multiple components of the defense response depend on orexin: evidence from orexin knockout mice and orexin neuron-ablated mice. Auton. Neurosci. 2006, 126-127:139-145.
61. Ziolkowska A., Spinazzi R., Albertin G., Nowak M., Malendowicz L.K., Tortorella C., et al. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor. J. Steroid Biochem. Mol. Biol. 2005, 96:423-429.